Triclosan-coated sutures and sternal wound infections: a prospective randomized clinical trial
- 2 October 2015
- journal article
- clinical trial
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 34 (12) , 2331-2338
Abstract
Surgical site infection is a common complication following cardiac surgery. Triclosan-coated sutures have been shown to reduce the rate of infections in various surgical wounds, including wounds after vein harvesting in coronary artery bypass grafting patients. Our purpose was to compare the rate of infections in sternotomy wounds closed with triclosan-coated or conventional sutures. A total of 357 patients that underwent coronary artery bypass grafting were included in a prospective randomized double-blind single-center study. The patients were randomized to closure of the sternal wound with either triclosan-coated sutures (Vicryl Plus and Monocryl Plus, Ethicon, Inc., Somerville, NJ, USA) (n = 179) or identical sutures without triclosan (n = 178). Patients were followed up after 30 days (clinical visit) and 60 days (telephone interview). The primary endpoint was the prevalence of sternal wound infection according to the Centers for Disease Control and Prevention (CDC) criteria. The demographics in both groups were comparable, including age, gender, body mass index, and rate of diabetes and smoking. Sternal wound infection was diagnosed in 43 patients; 23 (12.8 %) sutured with triclosan-coated sutures compared to 20 (11.2 %) sutured without triclosan (p = 0.640). Most infections were superficial (n = 36, 10.1 %), while 7 (2.0 %) were deep sternal wound infections. There were 16 positive cultures in the triclosan group and 17 in the non-coated suture group (p = 0.842). The most commonly identified main pathogens were Staphylococcus aureus (45.4 %) and coagulase-negative staphylococci (36.4 %). Skin closure with triclosan-coated sutures did not reduce the rate of sternal wound infection after coronary artery bypass grafting. (clinicaltrials.gov: NCT01212315)Keywords
This publication has 24 references indexed in Scilit:
- Effectiveness of triclosan-coated PDS Plus versus uncoated PDS II sutures for prevention of surgical site infection after abdominal wall closure: the randomised controlled PROUD trialThe Lancet, 2014
- Meta-Analysis of Prevention of Surgical Site Infections following Incision Closure with Triclosan-Coated Sutures: Robustness to New EvidenceSurgical Infections, 2014
- Prevention of sternal wound complications after sternotomy: results of a large prospective randomized multicentre trial†Interactive CardioVascular and Thoracic Surgery, 2013
- Staphylococcus epidermidis Isolated in 1965 Are More Susceptible to Triclosan than Current IsolatesPLOS ONE, 2013
- Gentamicin collagen sponges for the prevention of sternal wound infection: A meta-analysis of randomized controlled trialsThe Journal of Thoracic and Cardiovascular Surgery, 2012
- A 15-year study of the changing demographics and infection risk in a new UK cardiac surgery unitInteractive CardioVascular and Thoracic Surgery, 2012
- Efficiency of Antibacterial Suture Material in Cardiac Surgery: A Double-Blind Randomized Prospective StudyThe Heart Surgery Forum, 2012
- An update review on risk factors and scales for prediction of deep sternal wound infectionsInternational Wound Journal, 2011
- Surgical wound infection as a performance indicator: agreement of common definitions of wound infection in 4773 patientsBMJ, 2004
- Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical proceduresThe Annals of Thoracic Surgery, 1999